Healing diabetic neuropathic foot ulcers: are we getting better?
- 20 December 2004
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 22 (2) , 172-176
- https://doi.org/10.1111/j.1464-5491.2004.01375.x
Abstract
Aim To benchmark by year the likelihood that an individual with a diabetic neuropathic foot ulcer will heal over more than a 10‐year period.Patients and methods A cohort study within a multicentre wound care network of individuals with a diabetic neuropathic foot ulcer who were treated by a standard wound care algorithm. The main outcome was a healed wound by the 20th week of care stratified by calendar year.Results We evaluated 27 193 individuals with a neuropathic foot ulcer. Between 1988 and 1990 approximately 66% of patients did not heal. By 1999 this percentage had decreased to 49%. The change in the rate of failure to heal is very closely associated with an increase over time in the proportion of patients seen with wounds identified as prognostically favourable using a previously published prognostic model (i.e. individuals with wounds ≤ 2 cm2, wounds ≤ 2 months old, and wounds of grade ≤ 2). Nevertheless, even among those most likely to heal, the likelihood of failing to heal went from 62% prior to 1991 to 32% in 2000.Conclusions We have shown that individuals with a diabetic neuropathic foot ulcer seeking care are more likely to heal today than 10 years ago. The primary reason for this improvement is that individuals are seeking care when their wounds are most easily treated and these are now more likely to heal.Keywords
This publication has 23 references indexed in Scilit:
- Surrogate End Points for the Treatment of Diabetic Neuropathic Foot UlcersDiabetes Care, 2003
- Growth factors in the treatment of diabetic foot ulcersBritish Journal of Surgery, 2003
- Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetesDiabetologia, 2002
- Ethnicity and Risk of Diabetes-Related Lower Extremity AmputationArchives of internal medicine (1960), 2002
- Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.Diabetes Care, 1999
- Efficacy and Safely of a Topical Gel Formulation of Recombinant Human Platelet-Derived Growth Factor-BB (Becaplermin) in Patients With Chronic Neuropathic Diabetic Ulcers: A phase III randomized placebo-controlled double-blind studyDiabetes Care, 1998
- A Foot Risk Classification System to Predict Diabetic Amputation in Pima IndiansDiabetes Care, 1996
- Use of Dermagraft, a Cultured Human Dermis, to Treat Diabetic Foot UlcersDiabetes Care, 1996
- Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcersJournal of Vascular Surgery, 1995
- Risk Factors for Amputation in Patients with Diabetes MellitusAnnals of Internal Medicine, 1992